9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Olaparib in People With Malignant Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Olaparib in People With Malignant Mesothelioma

Olaparib in People With Malignant Mesothelioma

Estimated reading time: < 1 min

Condition: Mesothelioma

Estimated Enrollment: 40

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: objective response rate,  ,  ,

Interventions: Olaparib,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: June 30, 2020

Completion Date: December 1, 2020

Last  Posted Date: July 16, 2019

Location: National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Website Link: https://ClinicalTrials.gov/show/NCT03531840

Was this article helpful?
Dislike 0